Therachon raises $60 million in mezzanine financing for rare disease drugs
The Basel, Switzerland-based biotech company plans to trial the drug in achondroplasia patients next year.
Versant’s new $400M fund will be early-stage, global and appealing to Big Pharma
Versant Ventures will start the year with a new $400 million fund. The firm is doubling-down in high potential disease areas, overlooked regions, and startups that can be acquired by Big Pharma or taken through to an IPO.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Morning Read: 23andMe releases transparency report on law enforcement data requests
Also, Versant Ventures announces investment in Turnstone Biologics and the Senate is planning a budget vote to repeal major Obamacare mandates and defund Planned Parenthood as early as November.
Medtech venture capital: Opportunistic vs. commitment styles of investment
Venture capitalists have been criticized of late for their opportunistic investing choices in medical devices – moving away from early stage investment and into safer, later-stage deals that herald larger returns. Early stage investment, dubbed commitment investing, requires that they accept a longer wait to exit. This is all but dying out in medical device venture capital – making it harder […]
Bayer contributes $25M to Versant Ventures’ new fund
Bay Area venture capital firm Versant Ventures has teamed up with Bayer HealthCare to create a new fund that invest in biotech and medical device companies that target unmet medical needs. Bayer’s contributing up to $25 million to Versant Venture Capital V, though it’s only one of several investors to make up the fund, the companies said in a […]
Versant Ventures seeks $250M for next medtech venture capital fund
Though lots of venture capital for medtech has evaporated, Versant Ventures now seeks $250 million for its fifth medtech fund. The venture capital firm, which has strong presence in biotech and medtech, has a diverse California and Minnesota-based portfolio that includes medical device companies such as Respicardia, Zyga Technology and Autonomic Technologies. According to a […]
presented by
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
These are the most active VCs in healthcare since 2012
As investments in life science companies have dipped over the past few years, some investors have scaled back investments or walked away from the sector all together. But based on a tally by investment research firm PitchBook in its 2013 Venture Capital Healthcare Report, several firms have made 10 or more investments in pharmaceutical, medical […]
Medtech investors explain the nuances of evaluating reimbursement risk
It’s not as simple as “Do I have a code?” A “early stage vs. late stage” panel at today’s MedTech Investing conference in Minneapolis talked about what questions they ask when determining whether payers will reimburse new products and services. Investors have to consider multiple definitions of “value,” out-of-pocket possibilities, and the possibility of shifting […]
Three examples of how “the system” is changing medtech investment decisions
Will Kaiser pay for this? Kirk Nielsen of Versant Ventures said that has become the litmus test for healthcare investing in the new world of healthcare reform. An “early stage vs. late stage” panel at today’s MedTech Investing conference in Minneapolis showed how venture capitalists of all types are changing their evaluation process as healthcare […]
Ophthalmology incubator’s latest spinout — backed by big VC firms — raises $8 million
The fifth company spun out by the ophthalmology-focused incubator formed by Versant Ventures, Morgenthaler Ventures and Split Rock Partners has raised $8 million.
Maximize Revenue and Patient Care with Strategic Weight Loss Management
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
RNAi drug delivery company secures $1.6M for endosomal escape technology
PhaseRx is developing a RNAi drug delivery system that uses synthetic polymers to help RNAi-based therapeutics escape endosomes and reach cell cytoplasm.
Cardiac Concepts grabs $27M for sleep apnea pacing device
Cardiac Concepts Inc. has raised $27.2 million from the sale of equity. The company, based in Minnetonka, Minnesota, is developing a pacemaker-like device that uses electricity to treat sleeping disorders.
Morning Read: The biggest nursing strike in U.S. history?
Highlights of the important and the interesting from the world of healthcare: The biggest nursing strike in U.S. history? It could be coming to Minnesota. Fourteen nonprofit hospitals in the Minneapolis-St. Paul region could face a June 1 strike by 12,000 nurses depending on the outcome of a May 19 strike vote by the Minnesota […]
RedBrick Health co-founder raises $2 million for new start-up Bloom Health
Bloom Health Corp., a Minneapolis-based start-up that advises companies, employees and consumers on health care issues, is seeking a total of $5 million through the sale of equity and warrants and/or options, according to documents filed with the Securities and Exchange Commission.
RedBrick Health lands third $15 million investment
It plans to use the money to expand and market it Health Earnings System, which provides insurance for self-insured empoyers and offers rewards to employees who take part in certain health programs and guidelines. The company promises that anyone who "actively participates" in its health program "regardless of current health condition" pays less for their health care.